MEENAKSHI ANURAG to Trastuzumab
This is a "connection" page, showing publications MEENAKSHI ANURAG has written about Trastuzumab.
Connection Strength
0.376
-
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers. Cell Rep Med. 2025 Jun 17; 6(6):102154.
Score: 0.223
-
Microscaled proteogenomic methods for precision oncology. Nat Commun. 2020 Jan 27; 11(1):532.
Score: 0.154